Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Wave Life Sciences Ltd. Director's Dealing 2017

Feb 2, 2017

31900_dirs_2017-02-01_fc010fe4-b153-4372-a919-14cef5d57c8b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Wave Life Sciences Ltd. (WVE)
CIK: 0001631574
Period of Report: 2017-02-01

Reporting Person: Rawcliffe Adrian (Director)

More from Wave Life Sciences Ltd.

Regulatory Filings 2026
May 18
Interim / Quarterly Report 2026
Apr 28
Regulatory Filings 2026
Apr 28
Regulatory Filings 2026
Apr 21
Regulatory Filings 2026
Apr 15
Major Shareholding Notification 2026
Mar 31
Director's Dealing 2026
Mar 31
Regulatory Filings 2026
Mar 26
Director's Dealing 2026
Feb 28
Annual Report 2026
Feb 26
View all filings →